Hospital data helps predict risk of pneumonia after heart surgery
Pneumonia is the most prevalent infection after open-heart surgery, leading to longer hospital stays and lower odds of survival.
Jul 26, 2016
0
3
Pneumonia is the most prevalent infection after open-heart surgery, leading to longer hospital stays and lower odds of survival.
Jul 26, 2016
0
3
The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions ...
Jul 6, 2016
0
4
An Emory study published online this week in Circulation Research suggests that a disruption in the body's own regenerative capacity, measured by levels of circulating progenitor cells, may contribute to the development of ...
Jun 13, 2016
0
1
(HealthDay)—Venclexta (venetoclax) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia (CLL) characterized by a specific chromosomal abnormality called the 17p deletion.
Apr 11, 2016
0
0
Teams of researchers from the University of Illinois at Urbana-Champaign (UIUC) have demonstrated a biosensor capable of counting the blood cells electrically using only a drop of blood. The blood cell count is among the ...
Dec 18, 2015
0
16
(HealthDay)—Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among adults undergoing cancer chemotherapy.
Sep 2, 2015
0
14
Manchester researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy.
Mar 25, 2015
0
37
(HealthDay)—The U.S. Food and Drug Administration has approved the first device to treat dialysis-related amyloidosis (DRA), a complication of dialysis used to treat kidney failure.
Mar 6, 2015
0
7
Many patients with cancer experience low blood counts, which causes weakness and fatigue. Researchers at Karolinska Institutet in Sweden and colleagues from China and the UK have discovered how a tumour affects a patient's ...
Oct 13, 2014
1
0
(HealthDay)—When given to pregnant women, a common treatment for ulcerative colitis may inadvertently lower their baby's ability to fight off infections at birth, new French research suggests.
Oct 3, 2014
0
0